Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Telemedicine cardiac rehabilitation program

Official title: Implementation and Evaluation of Telemedicine in Cardiac Rehabilitation - a Study on Health Literacy, Health Related Quality of Life, and Family Support

Run by Copenhagen University Hospital, Hvidovre · NCT06320652 · Data updated 2026-11-12

This project tests whether a tailored telemedicine cardiac rehabilitation program with video consultations and home monitoring helps patients and their families improve health literacy and quality of life after heart disease.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment140 (estimated)
SponsorCopenhagen University Hospital, Hvidovre
Academic / other
Locations1 site (Hvidovre)
StatusRecruiting
StartedMay 2, 2024
Main results expectedDecember 31, 2025
Study endsAugust 31, 2027
Registry record updatedAugust 5, 2025
Trial IDNCT06320652 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults attending outpatient cardiac rehabilitation at Amager and Hvidovre Hospitals with ischemic heart disease, heart failure, persistent atrial fibrillation, or post-cardiac valve surgery who can use a smartphone, tablet, or computer and communicate in the study language.

Probably not a fit

Patients with substantial language barriers, significant cognitive impairment, or inability to use digital devices are unlikely to benefit from this telemedicine approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project uses an MRC-inspired complex intervention framework and a patient-and-family participatory design to build a tailored telerehabilitation model. First, the team will co-create the intervention with patients and families; second, they will run a quasi-experimental comparison between the telerehabilitation group and a usual-care control group; third, they will conduct qualitative participant observation and interviews to explore patient experience. The intervention is delivered via video consultations and home monitoring and targets outcomes such as health literacy, health-related quality of life, family support, and communication with outpatient nurses. Quantitative measures and descriptive qualitative methods will be combined to understand both effect and experience.

Why it matters

Potential benefit: If successful, the program could improve patients' understanding of their condition, strengthen family support, and make rehabilitation more convenient through remote care.

How similar studies have gone: Previous cardiac telerehabilitation studies have shown comparable clinical and quality-of-life outcomes and improved access, but a tailored, patient-and-family co-created model like this remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients and their family members affiliated with the Department of Cardiology at Amager and Hvidovre Hospital and attending cardiac rehabilitation.
* Patients diagnosed with ischemic heart disease, heart failure, persistent atrial fibrillation, and cardiac valve surgery.

Exclusion Criteria:

* Patients with substantial language barriers and limited cognitive function.
* Patients who can't use a smart phone, tablet, or computer.

Where it's running

  • University Hospital Amager and Hvidovre
    Hvidovre, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.